References

1.
Magill SS, O’Leary E, Janelle SJ, et al. Changes in Prevalence of Health Care Associated Infections in U.S. Hospitals. New England Journal of Medicine. 2018;379(18):1732-1744. doi:10.1056/NEJMoa1801550
2.
Pennsylvania Health Care Containment Council. Inpatient Utilization Report by County. https://www.phc4.org/reports/utilization/inpatient/
3.
Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP. The Preventable Proportion of Healthcare-Associated Infections 2005–2016: Systematic Review and Meta-Analysis. Infection Control & Hospital Epidemiology. 2018;39(11):1277-1295. doi:10.1017/ice.2018.183
4.
Scott RD, Division of Healthcare Quality Promotion National Center for Preparedness, Detection, and Control of Infectious Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention.; 2009. https://stacks.cdc.gov/view/cdc/11550
5.
Action Plan to Prevent Healthcare-Associated Infections. Department of Health and Human Services; 2009. https://www.hhs.gov/oidp/topics/health-care-associated-infections/hai-action-plan/index.html
6.
Centers for Disease Control and Prevention. National HAI Targets & Metrics. Published online 2021. https://www.hhs.gov/oidp/topics/health-care-associated-infections/targets-metrics/index.html
7.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2022. https://www.R-project.org/
8.
Centers for Disease Control and Prevention. Catheter-Associated Urinary Tract Infections (CAUTI). Healthcare-Associated Infections (HAIs). Published online 2015. https://www.cdc.gov/hai/ca_uti/uti.html
9.
Centers for Disease Control and Prevention. National Healthcare Safety Network (NHSN) Patient Safety Component Manual.; 2020. https://www.cdc.gov/nhsn/pdfs/validation/2020/pcsmanual_2020-508.pdf
10.
Lo E, Nicolle LE, Coffin SE, et al. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals: 2014 Update. Infection Control & Hospital Epidemiology. 2014;35(5):464-479.
11.
McGuckin M. The Patient Survival Guide: 8 Simple Solutions to Prevent Hospital and Healthcare-Associated Infections. (Goldfarb TL, Pronovost P, eds.). Demos Medical Publishing; 2012.
12.
Hollenbeak CS, Schilling AL. The Attributable Cost of Catheter-Associated Urinary Tract Infections in the United States: A Systematic Review. American Journal of Infection Control. 2018;46(7):751-757. doi:https://doi.org/10.1016/j.ajic.2018.01.015
13.
Patel PK, Advani SD, Kofman AD, et al. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute-Care Hospitals: 2022 Update. Infection Control & Hospital Epidemiology. 2023;44(8):1209--1231. doi:https://doi.org/10.1017/ice.2023.137
14.
APIC Implementation Guide: Guide to Preventing Central Line-Associated Bloodstream Infections. Association for Professionals in Infection Prevention; Epidemiology; 2015.
15.
Centers for Disease Control and Prevention. 2014 National and State Healthcare Associated Infections Progress Report.; 2016.
16.
Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project—Statistics on Hospital Stays.; 2013.
17.
Peasah S, McKay N, Harman J, Al-Amin M, Cook R. Medicare Non-Payment of Hospital-Acquired Infections: Infection Rates Three Years Post Implementation. Medicare & Medicaid Research Review. 2013;3(3):E1-E16. doi:10.5600/mmrr.003.03.a08
18.
Umscheid C, Mitchell M, Doshi J, Agarwal R, Williams K, Brennan P. Estimating the Proportion of Healthcare-Associated Infections That are Reasonably Preventable and the Related Mortality and Costs. Infection Control & Hospital Epidemiology. 2011;32(2):101--114. doi:10.1086/657912
19.
Buetti N, Marschall J, Drees M, Fakih MG, Hadaway L, Maragakis LL, Monsees E, Novosad S, O’Grady NP, Rupp ME, et al. Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute-Care Hospitals: 2022 Update. Infection Control & Hospital Epidemiology. 2022;43(5):553-569. doi:10.1017/ice.2022.87
20.
O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Summary of Recommendations: Guidelines for the Prevention of Intravascular Catheter-Related Infections. Clinical Infectious Diseases. 2011;9(52):1087-1099. doi:10.1093/cid/cir138
21.
Klevens RM, Edwards JR, Richards CL, et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
22.
Magill SS, Edwards JR, Bamberg W, et al. Multistate Point-Prevalence Survey of Health Care-Associated Infections. N Engl J Med. 2014;370(13):1198-1208.
23.
Mu Y, Edwards JT, Horan TC, Berrios-Torres SI, Fridkin SK. Improving Risk-Adjusted Measures of Surgical Site Infection for the National Healthcare Safety Network. Infect Control & Hosp Epidemiol. 2011;32(10):970-986.
24.
Lewis SS, Moehring RW, Chen LF, Sexton DJ, Anderson DJ. Assessing the Relative Burden of Hospital-Acquired Infections in a Network of Community Hospitals. Infect Control & Hosp Epidemiol. 2013;34(11):1229-1230.
25.
Ban KA, Minei JP, Laronga C, et al. Surgical Site Infection Guidelines, 2016 Update. Journal of the Americal College of Surgeons. 2016;224:59-74. doi:http://dx.doi.org/10.1016/j.jamcollsurg.2016.10.029
26.
Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surgery. 2017;152(8):784-791. doi:10.1001/jamasurg.2017.0904
27.
APIC Implementation Guide: Infection Preventionist’s Guide to the OR. Association for Professionals in Infection Prevention; Epidemiology; 2018.
28.
Calderwood MS, Anderson DJ, Bratzler DW, et al. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2022 Update. Infection Control & Hospital Epidemiology. 2022;44(5):695--720. doi:10.1017/ice.2023.67
29.
Dubberke E, Carling P, Carrico R, et al. Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update. Infection Control & Hospital Epidemiology. 2014;35(6):628--645. doi:10.1086/676023
30.
Shaughnessy M, Micielli R, DePestel D, et al. Evaluation of Hospital Room Assignment and Acquisition of Clostridium difficile Infection. Infection Control & Hospital Epidemiology. 2011;32(3):201--206. doi:10.1086/658669
31.
Sood G, Truelove S, Dougherty G, Landrum BM, Qasba S, Patel M, Miller A, Wilson C, Martin J, Sears C, Schuster A, Sulkowski M, Bennett R, Galai N. Clostridium difficile Infection (CDI) in a Previous Room Occupant Predicts CDI in Subsequent Room Occupants across Different Hospital Settings. American Journal of Infection Control. 2022;50(12):1352-1354. doi:https://doi.org/10.1016/j.ajic.2022.02.006
32.
Magill SS, O’Leary E, Ray SM, Kainer MA, Evans C, Bamberg WM,, et. al and Emerging Infections Program Hospital Prevalence Survey Team. Antimicrobial Use in US Hospitals: Comparison of Results From Emerging Infections Program Prevalence Surveys, 2015 and 2011. Clinical Infectious Diseases. 2020;72(10):1784-1792. doi:10.1093/cid/ciaa373
33.
Guh A, Mu Y, Winston L, Johnston H, Olson D, Farley M, Wilson L, Holzbauer S, Phipps E, Dumyati G, Beldavs Z, Kainer MA, Karlsson M, Gerding DN, McDonald LC, and Emerging Infections Program Clostridioides difficile Infection Working Group. Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes. The New England Journal of Medicine. 2020;382(14):1320-1330. doi:10.1056/NEJMoa1910215
34.
McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases. 2018;66(7):e1-e48. doi:10.1093/cid/cix1085
35.
Shrestha MP, Bime C, Taleban S. Decreasing Clostridium difficile–Associated Fatality Rates Among Hospitalized Patients in the United States: 2004-2014. The American Journal of Medicine. 2018;131(1):90--96. doi:10.1016/j.amjmed.2017.07.022
36.
Forster AJ, Taljaard M, Oake N, Wilson K, Roth V, van Walraven C. The Effect of Hospital-Acquired Infection with Clostridium. Canadian Medical Association Journal. 2012;184(1):37--42. doi:10.1503/cmaj.110543
37.
Reveles KR, Lawson KA, Mortensen EM, et al. National Epidemiology of Initial and Recurrent Clostridium difficile Infection in the Veterans Health Administration from 2003 to 2014. Plos One. 2017;12(12). doi:10.1371/journal.pone.0189227
38.
APIC Implementation Guide: Guide to Preventing Clostridium Difficile Infections. Association for Professionals in Infection Prevention; Epidemiology, APIC; 2013.
39.
Centers for Disease Control and Prevention. Healthcare Settings | MRSA | CDC. Published online 2019. https://www.cdc.gov/mrsa/healthcare/index.html
40.
Calfee DP, Salgado CD, Milstone AM, et al. Strategies to Prevent Methicillin-Resistant Staphylococcus aureus Transmission and Infection in Acute Care Hospitals: 2014 Update. Infection Control & Hospital Epidemiology. 2014;35(7):772-796. doi:10.1086/676534
41.
Jackson KA, Bohm MK, Brooks JT, et al. Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016. MMWR Morb Mortal Wkly Rep. 2018;67:625--628. doi:10.15585/mmwr.mm6722a2
42.
Kourtis AP, Hatfield K, Bagg JS, et al. Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States. MMWR Morb Mortal Wkly Rep. 2019;68(9):214--219. doi:http://dx.doi.org/10.15585/mmwr.mm6809e1
43.
Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus. Published online 2023. https://arpsp.cdc.gov/profile/nhsn/mrsa
44.
Centers for Disease Control and Prevention. Preventing Infections in Healthcare | MRSA | CDC. Published online 2019. https://www.cdc.gov/mrsa/healthcare/inpatient.html
45.
Centers for Disease Control and Prevention. Strategies to Prevent Hospital-Onset Staphylococcus aureus Bloodstream Infections in Acute Care Facilities. Published online 2019. https://www.cdc.gov/hai/prevent/staph-prevention-strategies.html
46.
Banach D, Bearman G, Barnden M, et al. Duration of Contact Precautions for Acute-Care Settings. Infection Control & Hospital Epidemiology. 2018;39(2):127--144. doi:10.1017/ice.2017.245
47.
Institute S. SAS User’s Guide: Statistics. Vol 2. Sas Inst; 1985.
48.
Centers for Disease Control and Prevention. The NHSN Standardized Infection Ratio (SIR): A Guide to the SIR. Centers for Disease Control; Prevention; 2022. https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sir-guide.pdf
49.
Centers for Disease Control and Prevention. 2020 National and State Healthcare-Associated Infections Progress Report.; 2021.
50.
Kepner S, Harper A, Jones R. 2020 Healthcare-Associated Infections in the Long-Term Care Setting: An Analysis of Reports from Pennsylvania. Patient Safety. 2021;3(2):22-33. doi:https://doi.org/10.33940/data/2021.6.2